Alphavax
The alphavaccine technology is based on AlphaVax’s proprietary replicon vector platform derived from attenuated strains of the alphavirus, Venezuelan equine encephalitis (VEE) virus. Industry interest in the alphavaccine technology has increased as vaccine candidates move through the development pipeline.
Crunchbase URL
DUNS Number
48731504
Email Address
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
Official Website
Find more companies like Alphavax
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.